eXoZymes
Update in progressEXOZ (NasdaqCM)
- Company RatingNeutralCompany RatingCombines sentiment and sustainability signals into an overall assessment of the company.Great · Good · Neutral · At Risk · Poor
- SectorHealthcare
- IndustryBiotechnology
eXoZymes, Inc. is a development-stage biotechnology company focused on creating enzyme modules and cell-free exozyme biosolutions for synthetic biology manufacturing. Formerly Invizyne Technologies, Inc., it renamed to eXoZymes in February 2025. The company was incorporated in 2014 and is based in Monrovia, California, with a mission to enable efficient, scalable biomanufacturing solutions.
Company score
- Sentiment
- 0.39
- SentimentMeasures the overall tone of recent coverage and discussion about the company.−10 negative · 0 neutral · +10 positive
- Environment
- 0.11
- EnvironmentAssesses the company’s environmental impact, risks, and sustainability practices.−10 negative · 0 neutral · +10 positive
- Social
- 0.00
- Governance
- 0.00
- GovernanceAssesses leadership, accountability, transparency, and business ethics.−10 negative · 0 neutral · +10 positive
- Sustainability
- 0.04
- SustainabilityCombines environmental, social, and governance signals into an overall sustainability score.−10 negative · 0 neutral · +10 positive
- Impact Score
- 0.21
- Impact ScoreCombines sentiment and sustainability performance into an assessment of the company’s overall impact.−10 negative · 0 neutral · +10 positive
Company
- MarketNasdaqCM (NCM)
- LocationUnited States
- CEOMr. Michael Heltzen
- Founded2014
- Employees32
- Websitewww.exozymes.com
Identifiers
- ISINUS4618741098
- FIGIBBG01LFVT4P0
- CUSIP461874109
- CIK0002010788